The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999
Stroke Location is Not Associated with Return to Work After First Ischemic Stroke
Stroke 30:2568-2573, Wozniak,M.A.,et al, 1999
Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999
Evaluating Dizziness
Am J Med 107:468-478, Hoffman,R.M.,et al, 1999
Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Fatal Cerebral Reperfusion Hemorrhage after Carotid Stenting
Stroke 30:2483-2486, McCabe,D.J.H.,et al, 1999
Neuropsychological and Quality of Life Outcome after Thalamic Stimulation for Essential Tremor
Neurol 53:1774-1780, Troster,A.I.,et al, 1999
Tube Feeding in Patients with Advanced Dementia,A Review of the Evidence
JAMA 282:1365-1370, Finucane,T.E.,et al, 1999
Moderate Hypothermia for Uncontrolled Intracranial Hypertension in Acute Liver Failure
Lancet 354:1164-1168, Jalan,R.,et al, 1999
Neurologic Complications of Pediatric Lung Transplantation
Neurol 53:1542-1549, Wong,M.,et al, 1999
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Fatal Encephalitis Due to Nipah Virus Among Pig-Farmers in Malaysia
Lancet 354:1257-1259,1222, Chua,K.B.,et al, 1999
Exotic Diseases Close to Home
Lancet 354:1221,1261, Briese,T.,et al, 1999
When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999
Bilateral Intracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry
Arch Neurol 56:1353-1358,1329, Shin,H-K.,et al, 1999
Mechanisms and Clinical Features of Posterior Border-Zone Infarcts
Neurol 53:1312-1318, Belden,J.R.,et al, 1999
Mortality from Dementia in Occupations at Risk of Exposure to Bovine Spongiform EncephalopathyAnalysis of Death Registrations
BMJ 318:1044-1045, Aylin,P.,et al, 1999
MR of CNS Sarcoidosis:Correlation of Imaging Features to Clinical Symptoms and Response to Treatment
AJNR 20:655-669, Christoforidis,G.A.,et al, 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
A 10-Year Study of Mortality in a Cohort of Patients with Myotonic Dystrophy
Neurol 52:1658-1662, Mathieu,J.,et al, 1999
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Brachial Palsies from Obstetric procedures
Lancet 354:614-615, Kay,S., 1999
Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999
Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999
The North American Symptomatic Carotid Endarterectomy Trial, Surgical Results in 1415 Patients
Stroke 30:1751-1758,1745, Ferguson,G.G.,et al, 1999
Medical Complications Associated with Carotid Endarterectomy
Stroke 30:1759-1763, Paciaroni,M.,et al, 1999
Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999
Age and Cause of Death in Mitochondrial Diseases
Neurol 53:855-857, Klopstock,T.,et al, 1999
Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999
Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999
Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Treatment of Attention-Deficit-Hyperactivity Disorder
NEJM 340:780-788, Elia,J.,et al, 1999
Early Prognostic Indicators of Outcome in Infants with Neonatal Cerebral Infarction:A Clinical,Electroencephalogram,and Magnetic Resonance Imaging Study
Pediatrics 103:39-46, Mercuri,E.,et al, 1999
Epstein-Barr Virus in Monitoring the Response to Therapy of Acquired Immunodeficiency-Related Primary Central Nervous System Lymphoma
Ann Neurol 5:259-261, Antinori,A.,et al, 1999
Progression of Parkinsonian Signs in Parkinson Disease
Arch Neurol 56:334-337, Louis,E.D.,et al, 1999
Pain after Whiplash:A Prospective Controlled Inception Cohort Study
JNNP 66:279-283, Obelieniene,D.,et al, 1999
A Critical Appraisal of the Chronic Whiplash Syndrome
JNNP 66:273-276, Pearce,J.M.S., 1999
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Lack of Effectiveness of Bed Rest for Sciatica
NEJM 340:418-423, Vroomen,P.C.A.J.,et al, 1999
Follow-up of Conservatively Managed Epidural Hematomas:Implications for Timing of Repeat CT
AJNR 20:107-113,115, Sullivan,T.P.,et al, 1999
Churg-Strauss Syndrome, Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine 78:26-37, Guillevin,L.,et al, 1999
Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999
Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999
Intracranial Internal Carotid Artery Angioplasty:Technique with Clinical and Radiographic Results and Follow-Up
AJR 172:703-707, Eckard,D.A.,et al, 1999
Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999